Advertisement

Mobile Banner
Mobile Banner
Mobile Banner
Loading...

Standard BioTools Inc.

FLDM•NASDAQ
Healthcare
Medical - Diagnostics & Research
$3.71
$-0.28(-7.02%)
U.S. Market opens in 11h 7m

Standard BioTools Inc. (FLDM) Stock Overview

Explore Standard BioTools Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap294.2M
P/E Ratio-7.91
EPS (TTM)$-0.78
ROE-0.41%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year Target$0.00

FLDM Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Standard BioTools Inc. (FLDM) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of $0.00.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -7.91 and a market capitalization of 294.2M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
N/A
3-Month Change
N/A
6-Month Change
N/A
Year-to-Date (YTD) Change
N/A
1-Year Change
5.70%
3-Year Change
6.92%
5-Year Change
-45.76%
All-Time (Max) Change
-73.54%

Contact Information

https://www.fluidigm.com
16502666000
7000 Shoreline Ct Ste 100, South San Francisco, CA, 94080

Company Facts

6,150 Employees
IPO DateFeb 10, 2011
CountryUS

Frequently Asked Questions